中国癌症杂志 ›› 2024, Vol. 34 ›› Issue (12): 1144-1163.doi: 10.19401/j.cnki.1007-3639.2024.12.009

• 指南与共识 • 上一篇    

间皮瘤组织病理学诊断临床实践指南(2025年版)

中国研究型医院学会病理学专业委员会, 上海市抗癌协会肿瘤病理专业委员会   

  • 收稿日期:2024-11-10 出版日期:2024-12-30 发布日期:2025-01-21
  • 通信作者: 李媛(ORCID: 0000-0001-5651-819X),主任医师,教授,复旦大学附属肿瘤医院病理科副主任;张智弘(ORCID: 0000-0002-5779-9365),主任医师,教授,江苏省人民医院病理科主任; 林冬梅(ORCID: 0000-0003-0532-7216),主任医师,教授,北京大学肿瘤医院病理科主任;高鹏(ORCID: 0000-0002-4721-0887),主任医师,教授,山东大学齐鲁医院病理科主任;王坚(ORCID: 0000-0002-7848- 803X),主任医师,教授,复旦大学附属肿瘤医院病理科主任。
  • 作者简介:朱培培(ORCID: 0000-0001-7175-9856),复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系。

Practice guideline for the histopathological diagnosis of mesothelioma (2025 version)

Expert Committee on Pathology of Chinese Research Hospital Association , Professional Committee on Tumor Pathology of Shanghai Anticancer Association   

  • Received:2024-11-10 Published:2024-12-30 Online:2025-01-21

摘要:

为了进一步提高中国间皮瘤的病理学诊断水平和病理学报告规范性,为病理科医师在临床实践中提供借鉴证据,为临床治疗和患者预后判断提供重要信息,中国研究型医院学会病理学专业委员会和上海市抗癌协会肿瘤病理专业委员会组织138位来自国内28个省市自治区的专家,组建《间皮瘤组织病理学诊断临床实践指南(2025年版)》制定专家团,设立指南工作组,涵盖病理、影像、肿瘤内科、胸外科、肿瘤预防、流行病学与卫生统计学等多学科,本着科学化、规范化、透明化和制度化的原则,基于现有循证医学证据,在文献检索和证据收集基础上,围绕间皮瘤病理学诊断最新进展,聚焦间皮瘤病理学诊断原则、免疫组织化学标志物和分子病理学检测,依据推荐分级的评估、制订和评价系统(Grading of Recommendations,Assessment,Development and Evaluation,GRADE)对循证医学证据质量和专家推荐意见强度进行质量等级分级和证据综合,采用德尔菲问卷调查法和共识会议法相结合,就间皮瘤病理学诊断相关“陈述”进行专家函询和投票审议,去重、合并和汇总临床问题,形成推荐意见。参照卫生保健实践指南报告条目(the Reporting Items for practice Guidelines in HealThcare,RIGHT)起草《间皮瘤组织病理学诊断临床实践指南(2025年版)》初稿,召开专家会议进行审核,并送外审专家评议,综合审定意见进行修改,形成终稿。本指南的目标人群为间皮瘤患者,使用人群为从事间皮瘤病理学诊断和辅助检测的医务工作者。本指南在国际实践指南注册与透明化平台(http://www.guidelines-registry.org)进行中英文双语注册,注册号为PREPARE-2024CN672,所撰写的指南计划书可从平台获取。

关键词: 间皮瘤, 病理学, 诊断, 指南

Abstract:

To improve the quality of pathologic diagnosis and enhance the standardization in pathological report of mesothelioma, Expert Committee on Pathology of Chinese Research Hospital Association and Professional Committee on Oncopathology of Shanghai Anticancer Association set up an expert team and establish guideline working groups, which embrace139 mutidisciplinary experts nationwide covering pathology, radiology, oncology, thoracic surgery, epidemiology and health statistics. Based on the principles of scientification, standardization, transparency and institutionalization with adherence to the international guidelines writing standards and guiding principles for the formulation/revision of clinical diagnosis and treatment guidelines in China, experts adopt evidence-based medicine methods, keep updated on the newest progress, focus on the diagnostic principles, immunohistochemistry and molecular pathology, establish quality evaluation and evidence summary, utilize the GRADE system and Delphi method in combination with multidisciplinary expert meetings, draft, modify and finalize this version of practice guideline for the histopathological diagnosis of mesothelioma. The target population and audience of the guideline center on patients with mesothelioma, whereas the users are medical staff engaged in pathological diagnosis and auxiliary testing of mesothelioma. This guideline has been registered in Practice Guide Registration for TransPAREncy (PREPARE) (http://www.guidelines-registry.org), with registration number PREPARE-2024CN672. The plan of the guideline can be obtained from the platform.

Key words: Mesothelioma, Pathology, Diagnosis, Guideline